Concourse Financial Group Securities, Inc. Sci Sparc Ltd. Transaction History

Concourse Financial Group Securities, Inc.

  • $1.56 Billion
  • Q2 2024

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023
BUY
$0.43 - $0.83 $0 - $0
0 New
0 $0
Q1 2023

May 15, 2023
BUY
$0.45 - $1.07 $0 - $0
0 New
0 $0
Q4 2022

Jan 30, 2023
BUY
$0.73 - $28.08 $0 - $0
0 New
0 $0
Q3 2022

Nov 15, 2022
BUY
$0.72 - $21.81 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022
BUY
$1.89 - $3.68 $0 - $0
0 New
0 $0
Q1 2022

May 09, 2022
BUY
$3.5 - $6.73 $0 - $0
0 New
0 $0
Q4 2021

Feb 07, 2022
BUY
$5.5 - $7.7 $0 - $0
0 New
0 $0

Others Institutions Holding SPRC

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About SciSparc Ltd.

SPRC Quotes by TradingView
  • Ticker SPRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 3,526,740
  • Market Cap $917K
  • Description
  • SciSparc Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include SCI-110 for the treatment of Tourette syndrome, obstructive sleep apnea, and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; and SCI-210 for the treatment of autism spectrum ...
More about SPRC
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email